Red Book 2018: Report of the Committee on Infectious Diseases / Edition 31 available in Paperback
Red Book 2018: Report of the Committee on Infectious Diseases / Edition 31
- ISBN-10:
- 1610021460
- ISBN-13:
- 9781610021463
- Pub. Date:
- 06/01/2018
- Publisher:
- American Academy of Pediatrics
- ISBN-10:
- 1610021460
- ISBN-13:
- 9781610021463
- Pub. Date:
- 06/01/2018
- Publisher:
- American Academy of Pediatrics
Red Book 2018: Report of the Committee on Infectious Diseases / Edition 31
Buy New
$149.95Buy Used
$149.95
-
$149.95
-
SHIP THIS ITEM
Temporarily Out of Stock Online
Please check back later for updated availability.
-
Overview
Extending an 8-decade tradition of excellence, Red Book® provides the most reliable and clinically useful information on the manifestations, etiology, epidemiology, diagnosis and treatment of more than 200 childhood infectious diseases. The 31st edition provides evidence-based guidance to practicing clinicians on pediatric infections and vaccinations based on the recommendations of the committee as well as the combined expertise of the CDC, the FDA, and hundreds physician contributors. New in Red Book 2018:
All chapters were assessed for relevance given the dynamic environment in pediatric medicine today and every chapter has been modified since the last edition
- 3 new chapters added (Chikungunya, Coagulase-Negative Staphylococcal Infections, and Zika).
- Standardized approaches to disease prevention through immunizations, antimicrobial prophylaxis, and infection-control practices have been updated throughout
- Recommendations for the use of doxycycline have been liberalized.
- References to evidence-based policy recommendations have been recommended
- Appropriate chapters have been updated to be consistent with 2018 AAP and CDC vaccine recommendations, CDC recommendations for immunization of health care personnel, and drug recommendations from 2018 Nelson's Pediatric Antimicrobial Therapy.
Product Details
| ISBN-13: | 9781610021463 |
|---|---|
| Publisher: | American Academy of Pediatrics |
| Publication date: | 06/01/2018 |
| Pages: | 1213 |
| Product dimensions: | 6.00(w) x 9.10(h) x 2.10(d) |
About the Author
Editor: David W. Kimberlin, MD, FAAP is the Principal Investigator for the Collaborative Antiviral Study Group (CASG), an international network of pediatric academic medical centers that evaluates antiviral therapeutics in rare diseases with a large unmet medical need, including neonatal herpes simplex virus (HSV) infections, congenital cytomegalovirus (CMV) disease, congenital Zika infection, neonatal and infantile influenza infection, and neonatal enteroviral sepsis syndrome. Studies conducted by the CASG have led to new drug indications and label changes for acyclovir, valganciclovir, and oseltamivir, and non-CASG studies conducted by Dr. Kimberlin also have led to label changes for valacyclovir.
Dr. Kimberlin is Editor of the 2018 AAP Report of the Committee on Infectious Diseases (Red Book), and was the editor for the 2015 edition as well. He is a Past-President of the Pediatric Infectious Diseases Society (PIDS), which is the world's largest organization of professionals dedicated to the treatment, control, and eradication of infectious diseases affecting children. Dr. Kimberlin also serves as Vice Chair for Clinical and Translational Research in the UAB Department of Pediatrics, where he holds the Sergio Stagno Endowed Chair in Pediatric Infectious Diseases and is Co-Director of the Division of Pediatric Infectious Diseases.
Associate editors:Michael T. Brady MD, FAAP is Professor of Pediatrics at The Ohio State University and Associate Medical Director at Nationwide Children’s Hospital. Dr. Brady was on the AAP Committee on Infectious Diseases from 2005 until 2014 (Chair from 2010 to 2014). Dr. Brady was an Associate Editor of the 2015 Red Book.
Dr. Brady received his medical degree from Jefferson Medical College in Philadelphia. His pediatric residency was completed at Nationwide Children’s Hospital in Columbus, Ohio and Baylor College of Medicine in Houston. His pediatric infectious diseases fellowship was at the Baylor College of Medicine. Dr. Brady’s special interests include HIV infection, healthcare-associated infections, perinatal infections and vaccine-preventable infections. He is currently a member of the Board of Scientific Counselors – Infectious Diseases at the Centers for Disease Control and Prevention.
Mary Anne Jackson, MD, FAAP: Following residency at Cincinnati Children’s and fellowship at the University of Texas Southwestern, Dr. Jackson has been a faculty member at Children’s Mercy Hospital, Kansas City since 1984 where she is Division Director of Infectious Diseases. She has won numerous teaching awards and was honored in 2012 as the outstanding graduate at the University of Missouri-Kansas City School of Medicine.
A fellow of the AAP, the Infectious Disease Society of America and the Pediatric Infectious Disease Society, she has also been elected to the American Pediatric Society, the Society of Pediatric Research and the Academic Pediatric Association.
She has been a member of the AAP Committee on Infectious Diseases since 2009, and is an Associate Editor of Red Book™ 2015. She has authored over 150 peer reviewed publications focusing on strategies to reduce the incidence of hospital acquired infection, judicious use of antibiotics, prevention of antibiotic resistant infection and vaccine implementation and education.Sarah S. Long, MD, FAAP is Section Chief of Infectious Diseases at St. Christopher’s Hospital for Children in Philadelphia, PA. Dr. Long is also Professor of Pediatrics at Drexel University College of Medicine.
Dr. Long is an associate editor of The Journal of Pediatrics and is the chief editor of the textbook Principles and Practice of Pediatric Infectious Diseases. She has received numerous teaching awards, the Distinguished Service Award of the Pediatric Infectious Diseases Society, the Clinical Teacher Award of the Infectious Diseases Society of America, and the Award for Lifetime Contribution to Infectious Diseases Education by the Section on Infectious Diseases of the American Academy of Pediatrics.
Dr. Long completed her medical degree at Jefferson Medical College in Philadelphia, and her residency and fellowship at St. Christopher’s Hospital for Children. She is board certified in pediatrics and pediatric infectious disease, and her principal areas of research are vaccine-preventable diseases and management of common infectious diseases in children. She sits on advisory committees for the National Institutes of Health, the Food and Drug Administration and the Centers for Disease Control and Prevention.
Table of Contents
Summary of Major Changes in the 2018 Red Book Section 1 Prologue Sources of Vaccine Information Discussing Vaccines with Patients and Parents Active Immunization Vaccine Ingredients Vaccine Handling and Storage Vaccine Administration Managing Injection Pain Scheduling Immunizations Minimum Ages and Minimum Intervals Between Vaccine Doses Interchangeability of Vaccine Products Simultaneous Administration of Multiple Vaccines Combination Vaccines Lapsed Immunizations Unknown or Uncertain Immunization Status Vaccine Dose Active Immunization of People Who Recently Received Immune Globulin and Other Blood Products Vaccine Safety IOM Reviews of Adverse Events After Immunization Vaccine Adverse Event Reporting System (VAERS) Vaccine Safety Datalink Project Postlicensure Rapid Immunization Safety Monitoring (PRISM) Clinical Immunization Safety Assessment (CISA) Project Vaccine Injury Compensation Hypersensitivity Reactions after Immunization Passive Immunization Immune Globulin Intramuscular (IGIM) Immune Globulin Intravenous (IGIV) Immune Globulin Subcutaneous (IGSC) Treatment of Anaphylactic Reactions Preterm and Low Birth Weight Infants Pregnancy Immunocompromised Children Children With a Personal or Family History of Seizure Children with Chronic Diseases American Indian/Alaska Native Children Adolescent and College Populations Health Care Personnel Children Who Received Immunizations Outside the US or Whose IZ Status is Unknown International Travel Section 2 Human Milk Children in Out-of-Home Child Care School Health Infection Control and Prevention for Hospitalized Children Infection Control and Prevention in Ambulatory Settings Sexually Transmitted Infections in Adolescents and Children Medical Evaluation for Infectious Diseases for Internationally Adopted, Refugee and Immigrant Children Injuries from Discarded Needles in the Community Bite Wounds Prevention of Tickborne Infections Prevention of Mosquitoborne Infections Prevention of Illnesses Associated with Recreational Water Use Section 3 Actinomycosis Adenovirus Infections Amebiasis Amebic Meningoencephalitis and Keratitis Anthrax Arboviruses Arcanobacterium haemolyticum Infections Ascaris lumbricoides Infections Aspergillosis Astrovirus Infections Babesiosis Bacillus cereus Infections Bacterial Vaginosis Bacteroides and Prevotella Infections Balantidium coli Infections (Balantidiasis) Baylisascaris Infections Blastocystis hominis Infections Blastomycosis Bocavirus Borrelia Infections (Relapsing Fever) Brucellosis Burkholderia Infections Campylobacter Infections Candidiasis Cat-Scratch Disease Chancroid Chikungunya Chlamydial Infections, Chlamydophila (formerly Chlamydia) pneumoniae Chlamydial Infections, Chlamydophila (formerly Chlamydia) psittaci (Psittacosis, Ornithosis, Parrot Fever) Chlamydial Infections, Chlamydia trachomatis Clostridial Infections, Botulism and Infant Botulism Clostridial Infections, Clostridial Myonecrosis Clostridial Infections, Clostridium difficile Clostridial Infections, Clostridium perfringens Food Poisoning Coccidiodomycosis Coronaviruses Cryptococcus neoformans and Cryptococcus gattii Infections Cryptosporidiosis Cutaneous Larva Migrans Cyclosporiasis Cytomegalovirus Infection Dengue Fever Diphtheria Ehrlichia, Anaplasma and Related Infections Enterovirus (Nonpoliovirus) Epstein-Bar Virus Infections Escherichia coli and Other Gram-Negative Bacilli Escherichia coli Diarrhea Fungal Diseases Fusobacterium Infections Giardia intestinalis Infections (Giardiasis) Gonococcal Infections Granuloma Inguinale Haemophilus influenzae Infections Hantavirus Pulmonary Syndrome Helicobacter pylori Infections Hemorrhagic Fevers Caused by Arenaviruses Hemorrhagic Fevers Caused by Bunyaviruses Hemorrhagic Fevers Caused by Filoviruses: Ebola and Marburg Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Herpes Simplex Histoplasmosis Hookworm Infections Human Herpesvirus 6 (Including Roseola) and 7 Human Herpesvirus 8 Human Immunodeficiency Virus Infection Influenza Isosporiasis Kawasaki Disease Kingella kingae Infections Legionella pneumophila Infections Leishmaniasis Leprosy Leptospirosis Listeria monocytogenes Infections Lyme Disease Lymphatic Filariasis Lymphocytic Choriomeningitis Malaria Measles Meningococcal Infections Human Metapneumovirus Microsporidia Infections Molluscum Contagiosum Moraxella catarrhalis Infections Mumps Mycoplasma pneumoniae Infections Nocardiosis Norovirus and Other Human Calicivirus Infections Onchocerciasis (River Blindness, Filariasis) Human Papillomavirus Paracoccidioidomycosis Paragonimiasis Parainfluenza Viral Infections Parasitic Diseases Human Parechovirus Infections Parvovirus B19 Pasteurella Infections Pediculosis Capitis Pediculosis Corporis Pediculosis Pubis Pelvic Inflammatory Disease Pertussis (Whooping Cough) Pinworm Infection Pityriasis Versicolor (Tinea Versicolor) Plague Pneumococcal Infections Pneumocystis jirovecci Infections Poliovirus Infections Polyomaviruses Prion Diseases, Transmissible Spongiform Encephalopathies Q Fever Rabies Rat-Bite Fever Respiratory Syncytial Virus Rhinovirus Infections Rickettsial Diseases Rickettsialpox Rocky Mountain Spotted Fever Rotavirus Infections Rubella Salmonella Infections Scabies Schistosomiasis Shigella Infections Smallpox (Variola) Sporotrichosis Staphylococcal Food Poisoning Staphylococcus aureus (formerly known as Staphylococcal Infections) Coagulase-negative Staphylococcal Infections Group A Streptococcal Infections Group B Streptococcal Infections Non-Group A or B Streptococcal and Enterococcal Infections Strongyloidiasis Syphilis Tapeworm Diseases (Taeniasis and Cysricercosis) Other Tapeworm Infections Tetanus Tinea Capitis Tinea Corporis Tinea Cruris Tinea Pedis and Tinea Unguium Toxocariasis Toxoplasma gondii Infections Trichinellosis Trichomonas vaginalis Infections Trichuriasis Africian Trypanosomiasis American Trypanosomiasis Tuberculosis Diseases Caused by Nontuberculous Mycobacteria Tularemia Endemic Typhus (murine typhus) Epidemic Typhus (louseborne or Sylvatic typhus) Ureaplasma urealyticum and Ureaplasma parvum Infections Varicella-Zoster Infections Vibrio Infections, Cholera Vibrio Infections, Other Vibrio Infections West Nile Virus Yersinia enterocolitica and Yersinia pseudotuberculosis Infections Zika Virus Section 4 Antimicrobial Agents and Related Therapy (AKA Introduction) Antimicrobial Resistance and Antimicrobial Stewardship: Appropriate and Judicious Use of Antimicrobial Agents Drug Interactions Tables of Antibacterial Drug Doses Sexually Transmitted Infections Antifungal Drugs for Systemic Fungal Infections Recommended Doses of Parenteral and Oral Antifungal Drugs Topical Drugs for Superficial Fungal Infections Non-HIV Antiviral Drugs Drugs for Parasitic Infections MEDWATCH-The FDA Safety Information and Adverse Event Reporting Program Section 5 Antimicrobial Prophylaxis Antimicrobial Prophylaxis in Pediatric Surgical Patients Prevention of Bactrial Endocarditis Prevention of Neonatal Ophthalmia Appendices Directory of Resources Codes for Commonly Administered Pediatric Vaccines/Toxoids and Immune Globulins National Childhood Vaccine Injury Act Reporting and Compensation Table Nationally Notifiable Infectious Diseases in the United States Guide to Contraindications and Precautions to Immunizations Prevention of Disease From Potentially Contaminated Food Products Clinical Syndromes Associated with Foodborne Diseases Diseases Transmitted by Animals (Zoonoses)